Vitamin D Deficiency in Pregnancy: Management Recommendations
All pregnant women should receive vitamin D supplementation of 600-1000 IU daily, and women with confirmed vitamin D deficiency require higher doses (1500-2000 IU daily) to achieve optimal serum 25-hydroxyvitamin D levels above 50 nmol/L (20 ng/mL). 1, 2
Screening and Target Levels
Routine screening is not necessary for all pregnant women, but testing should be considered for high-risk populations including:
- Women with obesity (BMI ≥30 kg/m²) 3
- Women with limited sun exposure
- Women with darker skin pigmentation
- Women after bariatric surgery 4
Target serum 25(OH)D concentration: ≥50 nmol/L (20 ng/mL), with optimal levels considered 75-125 nmol/L (30-50 ng/mL) 1, 5
Supplementation Strategy
For Prevention (All Pregnant Women)
- Standard dose: 600 IU (15 mcg) daily 1, 2
- Alternative dose: 1000 IU (25 mcg) daily has been shown safe and effective at achieving vitamin D repletion 3
- Higher-risk populations may benefit from 1500-2000 IU daily 2, 6
For Confirmed Deficiency
The 2024 Endocrine Society guideline 2 and global consensus recommendations 1 support:
- 1500-2000 IU daily for women with documented deficiency
- Continue throughout pregnancy and lactation
- Avoid bolus dosing (single doses >25,000 IU) during pregnancy 7
Special Populations
Women with obesity: Consider higher doses given increased risk of deficiency and lower serum folate levels even with supplementation 3
Post-bariatric surgery: Supplement with ≥40 mcg (1000 IU) daily, monitor levels each trimester, and adjust to maintain serum 25(OH)D ≥50 nmol/L with normal PTH 4
Clinical Benefits
The evidence suggests vitamin D supplementation during pregnancy may:
- Reduce preterm birth risk (moderate certainty evidence) 8, 9
- Reduce low birthweight risk (moderate certainty evidence) 8, 9
- Reduce severe postpartum hemorrhage (low certainty evidence) 8
- Possibly reduce pre-eclampsia risk (low certainty evidence) 2, 8, 9
A 2024 Cochrane review 8 found that vitamin D supplementation may reduce severe postpartum hemorrhage (RR 0.68,95%CI 0.51-0.91) and low birthweight (RR 0.69,95%CI 0.44-1.08), though the evidence certainty remains low to very low for most outcomes.
Monitoring
For women on standard prophylactic doses (600-1000 IU): No routine monitoring of 25(OH)D levels is required 2
For women on higher doses or with documented deficiency:
- Check 25(OH)D levels at baseline if deficiency suspected
- Recheck 3-6 months after dose adjustment 4, 5
- Monitor each trimester in post-bariatric surgery patients 4
Important Caveats
Do not combine vitamin D with calcium supplementation routinely, as this combination may increase preterm birth risk 3, 8, 9. The exception is post-bariatric surgery patients who require both to maintain normal PTH 4.
Avoid excessive supplementation: The tolerable upper limit is 4000 IU daily 10, 1. Vitamin D toxicity (defined as hypercalcemia with 25(OH)D >250 nmol/L) is rare at recommended doses 1.
Recent evidence suggests 1000 IU daily may be insufficient for many women with established deficiency, with 67% remaining deficient after 16 weeks of supplementation 11. This supports the Endocrine Society's recommendation for higher doses (1500-2000 IU) in deficient women 2.
Formulation
Cholecalciferol (vitamin D3) is preferred over ergocalciferol (vitamin D2) for supplementation 5. Calcifediol may be used as a second-line option 12.